KEY TAKEAWAY: Purdue’s layoff of 200 salespeople is proof just how bad and corrupt big pharma can stoop in order to try and protect dollars made by illegal marketing. Continue reading
KEY TAKEAWAY: 85% of the content on pharma product websites, has never been read by visitors so why doesn’t pharma optimize content to keep people on their website longer? Continue reading
KEY TAKEAWAY: “That’s a really high LDL,” according to Dr. Topol, a cardiologist at the Scripps Research Institute. “We’re talking about a 70-plus-year-old man who is obese and doesn’t exercise. Just looking at the lab value, you would raise a big red flag.” He added: “I would never use the words ‘excellent health.’ How you could take these indices and say excellent health? That is completely contradicted.” But the bigger danger is the message this sends to the public at large. Continue reading
KEY TAKEAWAY: Since 1980 and the Bayh-Dole Act, drug companies can feed off research funded by the National Institutes of Health, which they acquire at late stages of development. As pointed out by former New England Journal of Medicine editor Dr. Marcia Angell, the big companies can either license the drugs or buy out small biotech companies carrying out NIH-funded research. In short, much of the research going into these products is funded by taxpayers, not pharmaceutical revenues. Profits above taxpayers. Continue reading
I’m having a hard time understanding how anyone with a conscience could work for a company like Allergan. Transferring patents, rights to a native American tribe to try and circumvent the law and using DTC to market a drug that did nothing, according to JAMA but increase health care costs. Continue reading
KEY IDEA: The objective of DTC marketing is, and will always be, to generate new Rx’s for the product. While the idea of bringing patients together in community and sharing information is a good one too many drug companies are not willing to take the risk(s). Continue reading
-Consumer Reports survey of 1,200 adults who currently take prescription medications. During the past year, 22 percent of them—which comes to an estimated 27 million Americans—experienced a price hike for one or more of their medications.
-More than a quarter of people blamed their insurer for their drug price increase.
-According to the Centers for Disease Control and Prevention, nearly 40 percent of adults younger than 65 who get insurance through their employer had high-deductible plans in 2016. That’s up from 26 percent in 2011. Continue reading